The Middle EAST Epidemic Keratoconjunctivitis Treatment Market was valued at USD 0.15 billion in 2024 and is projected to reach USD 0.30 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by several factors, including an increasing incidence of epidemic keratoconjunctivitis (EKC) and a rising awareness of treatment options among healthcare providers and patients....